Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen

Details for Australian Patent Application No. 2009202656 (hide)

Owner Novartis AG

Inventors Woo, Margaret Ma; Schran, Horst F.

Agent Davies Collison Cave

Pub. Number AU-A-2009202656

Parent 2005226932

Filing date 30 June 2009

Wipo publication date 23 July 2009

International Classifications

A61K 31/4745 (2006.01)

A61K 31/00 (2006.01)

Event Publications

16 July 2009 Complete Application Filed

23 July 2009 Application Open to Public Inspection

  Published as AU-A-2009202656

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202657-Composite packaging

2009202655-Container